Related Experiment Videos
Kaposi's sarcoma: malignant tumor or proliferative disorder?
A Azzarelli1, V Mazzaferro, V Quagliuolo
1Division of Surgical Oncology 'A', Istituto Nazionale Tumori of Milano, Italy.
European Journal of Cancer & Clinical Oncology
|June 1, 1988
Summary
Classic Kaposi's sarcoma (KS) treatment shows a high recurrence rate, even after initial lesion control. Despite poor cure rates, mortality is low, suggesting a potentially non-tumoral disease pattern.
Area of Science:
- Oncology
- Dermatology
- Clinical Medicine
Background:
- Classic Kaposi's sarcoma (KS) presents unique clinical and pathological patterns.
- Understanding treatment response and disease course is crucial for managing KS patients.
Purpose of the Study:
- To analyze the clinical course and treatment response in 41 patients with classic Kaposi's sarcoma.
- To evaluate the efficacy of various therapeutic strategies for nodular and disseminated KS lesions.
Main Methods:
- Retrospective review of 41 classic Kaposi's sarcoma cases.
- Analysis of treatment modalities including surgery, chemotherapy, and radiation therapy (RT).
- Assessment of recurrence rates, disease-free intervals, and overall survival.
Main Results:
- 54% of patients with single nodular lesions experienced recurrence after surgery, with disease-free intervals up to 11 years.
- Combination therapy (surgery, chemo, RT) led to complete remission in disseminated KS for up to 40 months.
- Spontaneous regression was observed in 3 cases; overall disease-free rate was approximately 30%.
Conclusions:
- Kaposi's sarcoma has a low mortality rate despite a high risk of recurrence or dissemination.
- Effective control of the primary lesion does not guarantee prevention of recurrence, which can occur years later.
- The disease may exhibit non-malignant or non-tumoral characteristics, warranting exploration of alternative therapeutic strategies.